Home Daily Stock Opinions and Ratings Theragenics Corp (TGX-N)

Trending stocks today

Shift4 Payments Cellebrite Sprott Physical Gold Sprott Uranium Physical Trust Sprott Physical Silver Trust CAD Blue Bird Raytheon Toll Brothers Inc. Arista Networks Snowflake Datadog, Inc. Rivian Automotive Walmart Inc BP PLC Riley Exploration Permian, Inc. Matador Resources SM Energy Company MEG Energy Corp Arc Resources Ltd Tamarack Valley Energy

Theragenics Corp (TGX-N)

NEW AI Investor Insights
2 watching

0.00
0.00 (0.00%) 1d
0
PAST TOP PICK

Theragenics Corp(TGX-N)

06/12/2011
Theragenics Corp
(Top Pick Nov 11/10, Up 27.69%) Got tired of management – salaries were too high. They took on debt.
biotechnology / pharmaceutical
Benj Gallander
$1.660
No
UnlockRating
PAST TOP PICK

Theragenics Corp(TGX-N)

03/11/2011
Theragenics Corp
(A Top Pick Nov 11/10. Up 28.57%.)
biotechnology / pharmaceutical
Benj Gallander
$1.600
Owned
UnlockRating
PAST TOP PICK

Theragenics Corp(TGX-N)

04/10/2011
Theragenics Corp
(Top Pick Nov 11/10, Down 2.30%) out of it personally but fund holds it. Is on their buy list.
biotechnology / pharmaceutical
Benj Gallander
$1.250
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

11/11/2010
Theragenics Corp
Seeds for cancer patients but also do surgical products. Marginally profitable but revenues are up to record levels at about $80 million. Paying down debt. Would like to see a cleaner balance sheet.
biotechnology / pharmaceutical
Benj Gallander
$1.300
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

24/12/2007
Theragenics Corp
Cancer therapy. Revenues have grown. Acquired a $10 million company for $30 million, which was questionable. Fairly clean balance sheet.
biotechnology / pharmaceutical
Benj Gallander
$3.710
Owned
UnlockRating
WEAK BUY

Theragenics Corp(TGX-N)

06/10/2006
Theragenics Corp
Prostate cancer field. Recently expanded into all kinds of other medical devices, including some four cats and dogs. Made some poor acquisitions. Not happy with management.
biotechnology / pharmaceutical
Benj Gallander
$3.070
Owned
UnlockRating
PAST TOP PICK

Theragenics Corp(TGX-N)

30/01/2006
Theragenics Corp
(A Top Pick Sept 6/05. Up 9.5%.) They have cut out their R&D which will save them a lot of money. Acquired another firm which will increase their revenues. They have a beautiful balance sheet. Still have it on their BUY list.
biotechnology / pharmaceutical
Benj Gallander
$3.480
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

06/09/2005
Theragenics Corp
In the medical products field and treat prostate cancer. Their R&D over the last couple of years has not produced anything. Has a pretty good balance sheet and no debt. BV take a hit because they will be writing off their nuclear research assets. Restructuring and if they just do anything right they will be good as they are dominant in their field.
biotechnology / pharmaceutical
Ben Stadelmann
$3.150
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

12/01/2005
Theragenics Corp
They have an isotope that is a less invasive way of treating prostrate cancer as opposed to surgery. They're dominant in this field. Had difficulty because of insurance coverage issues. Their competition also has treatment methods, so have competition. Losing money because of more going into R & D. New marketing may help.
biotechnology / pharmaceutical
Ben Stadelmann
$3.970
Owned
UnlockRating
PAST TOP PICK

Theragenics Corp(TGX-N)

09/11/2004
Theragenics Corp
(A Top Pick June 14/04. Down 12%.) Have about $30 million in revenues. Operate in the prostrate cancer area which is a growing field. Still on their buy list, but wait until December for tax loss selling. No debt. Good management.
biotechnology / pharmaceutical
Benj Gallander
$3.900
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

16/09/2004
Theragenics Corp
A demographics play in treatment of prostrate cancer. Dominant in their field. Midicare payment problem seems to be getting worked out. R&D is looking for other cancer treatments.
biotechnology / pharmaceutical
Ben Stadelmann
$3.740
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

21/07/2004
Theragenics Corp
biotechnology / pharmaceutical
Benj Gallander
$4.360
Owned
UnlockRating
TOP PICK

Theragenics Corp(TGX-N)

16/07/2004
Theragenics Corp
Had revenues over $50 million and stock price was over $30. Revenues then dropped to $30 million. Prostate cancer continues to grow demographically and they have a proven product for this. A lot of competition. No long-term debt.
biotechnology / pharmaceutical
Benj Gallander
$4.370
Owned
UnlockRating
Showing 1 to 13 of 13 entries
  • «
  • ‹
  • 1
  • ›
  • »

Theragenics Corp(TGX-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Theragenics Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Theragenics Corp(TGX-N) Frequently Asked Questions

What is Theragenics Corp stock symbol?

Theragenics Corp is a OTC stock, trading under the symbol TGX-N on the (). It is usually referred to as or TGX-N

Is Theragenics Corp a buy or a sell?

In the last year, there was no coverage of Theragenics Corp published on Stockchase.

Is Theragenics Corp a good investment or a top pick?

Theragenics Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Theragenics Corp.

Why is Theragenics Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Theragenics Corp worth watching?

In the last year, there was no coverage of Theragenics Corp published on Stockchase.

What is Theragenics Corp stock price?

On , Theragenics Corp (TGX-N) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

NVA-TNuvista Energy Ltd
Nuvista Energy Ltd
$14.03
0.64 (4.36%)
PEY-TPeyto Exploration & Develop.
Peyto Exploration & Develop.
$17.08
0.88 (4.90%)
CVE-TCenovus Energy
Cenovus Energy
$22.64
0.02 (0.09%)
VRN-TVeren
Veren
$7.53
0.02 (0.26%)
PD-TPrecision Drilling
Precision Drilling
$92.36
1.29 (1.38%)
Advertising

Today's Top Picks

TVE-TTamarack Valley Energy
Tamarack Valley Energy
$4.55
0.12 (2.57%)
ARX-TArc Resources Ltd
Arc Resources Ltd
$26.97
0.74 (2.67%)
MEG-TMEG Energy Corp
MEG Energy Corp
$26.77
1.09 (3.91%)
SM-NSM Energy Company
SM Energy Company
$45.76
1.00 (2.14%)
MTDR-NMatador Resources
Matador Resources
$60.67
1.49 (2.40%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

PXT-TParex Resources Inc.
Parex Resources Inc.
$15.06
0.13 (0.82%)
PLTR-NPalantir Technologies
Palantir Technologies
$61.35
-0.77 (-1.27%)
DELL-NDell Computers
Dell Computers
$138.94
4.98 (3.46%)
ZQQ-TBMO NASDAQ 100 HEDGED TO CAD INDEX ETF
BMO NASDAQ 100 HEDGED TO CAD INDEX ETF
$145.12
0.66 (0.45%)
SOXX-QiShares PHLX Semiconductor ETF.
iShares PHLX Semiconductor ETF.
$216.90
4.19 (1.90%)

Most Recent Experts

Nuttall

Eric Nuttall

Ninepoint Partners

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Bolton

Kim Bolton

Black Swan Dexteritas

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.